Fertility and Sterility
Volume 89, Issue 3 , Pages 649-655 , March 2008

Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome

  • Elvira Maria Mafaldo Soares, M.D.

      Affiliations

    • Departamento de Tocoginecologia, Maternidade Escola Januário Cicco, Universidade Federal do Rio Grande do Norte, Natal-RN, Brazil
    • ,
  • George Dantas Azevedo, Ph.D.

      Affiliations

    • Departamento de Morfologia, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal-RN, Brazil
    • Corresponding Author InformationReprint requests: George Dantas Azevedo, Ph.D., Departamento de Morfologia do Centro de Biociências, Campus Universitário, BR 101, Lagoa Nova, Natal-RN, Brasil 59078-970 (FAX: +55-84-32119207).
    • ,
  • Rafael Gonçalves Nóbrega Gadelha, M.D.

      Affiliations

    • Departamento de Tocoginecologia, Maternidade Escola Januário Cicco, Universidade Federal do Rio Grande do Norte, Natal-RN, Brazil
    • ,
  • Telma Maria Araújo Moura Lemos, Ph.D.

      Affiliations

    • Departamento de Análises Clínicas, Centro de Ciências da Saúde, Programa de Pós-graduação em Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal-RN, Brazil
    • ,
  • Técia Maria Oliveira Maranhão, Ph.D.

      Affiliations

    • Departamento de Tocoginecologia, Maternidade Escola Januário Cicco, Universidade Federal do Rio Grande do Norte, Natal-RN, Brazil

Received 2 January 2007 ,Revised 28 March 2007 ,Accepted 28 March 2007.

References 

  1. Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853–861
  2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999;84:4006–4011
  3. Scarpitta AM, Sinagra D. Polycystic ovary syndrome: an endocrine and metabolic disease. Gynecol Endocrinol. 2000;14:392–395
  4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25
  5. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;8:774–800
  6. Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association?. Endocr Rev. 2003;24:302–312
  7. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–194
  8. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–1428
  9. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752
  10. Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism. 2003;52:908–915
  11. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:1929–1935
  12. Essah PA, Nestler JE. Metabolic syndrome in women with polycystic ovary syndrome. Fertil Steril. 2006;86(Suppl 1):S18–S19
  13. Vrbìková J, Vondra K, Cibula D, Dvorakova K, Stanicka S, Sramkova D, et al. Metabolic syndrome in young Czech women with polycystic ovary syndrome. Hum Reprod. 2005;20:3328–3332
  14. Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol. 2006;154:141–145
  15. Marcopito LF, Rodrigues SS, Pacheco MA, Shirassu MM, Goldfeder AJ, Moraes MA. Prevalence of a set of risk factors for chronic diseases in the city of Sao Paulo, Brazil. Rev Saude Publica. 2005;39:738–745
  16. Third Report of the National Cholesterol Education Program (NCEP) . Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421
  17. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA. 2003;100:177–182
  18. Pimenta JR, Zuccherato LW, Debes AA, Maselli L, Soares RP, Moura-Neto RS, et al. Color and genomic ancestry in Brazilians: a study with forensic microsatellites. Hum Hered. 2006;62:190–195
  19. Ferriman DG, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrino Metab. 1961;21:1440–1447
  20. World Health Organization. Obesity preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva 3–5 June, 1997.
  21. Barbieri RL, Ryan KJ. Hyperandrogenism, insulin resistance and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol. 1983;147:90–99
  22. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl 1):S5–S20
  23. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–2410
  24. Sociedade Brasileira de Hipertensão; Sociedade Brasileira de Cardiologia; Sociedade Brasileira de Endocrinologia e Metabologia; Sociedade Brasileira de Diabetes; Sociedade Brasileira de Estudos da Obesidade. I Brazilian guidelines on diagnosis and treatment of metabolic syndrome. Arq Bras Cardiol. 2005;84(Suppl 1):1–28
  25. de Oliveira EP, de Souza ML, de Lima MD. Prevalence of metabolic syndrome in a semi-arid rural area in Bahia. Arq Bras Endocrinol Metabol. 2006;50:456–465
  26. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359
  27. Sam S, Legro RS, Bentley-Lewis R, Dunaif A. Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;90:4797–4802
  28. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003;163:427–436
  29. Alvarez Cosmea A, Lopez Fernandez V, Suarez Garcia S, Arias Garcia T, Prieto Diaz MA, Diaz Gonzalez L. Differences in the prevalence of metabolic syndrome according to the ATP-III and WHO definitions. [in Spanish] Med Clin (Barc). 2005;124:368–370
  30. Vural B, Caliskan E, Turkoz E, Kilic T, Demirei A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod. 2005;20:2409–2413
  31. Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2006;65:137–145
  32. Faloia E, Canibus P, Gatti C, Frezza F, Santangelo M, Garrapa GG, et al. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. J Endocrinol Invest. 2004;27:424–429
  33. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. Diabetes Care. 2006;22:141–146
  34. Matos AFG, Moreira RO, Guedes EP. Neuroendocrinology of the metabolic syndrome. Arq Bras Endocrinol Metab. 2003;47:410–420
  35. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis. 2004;173:309–314
  36. Whitfield JB, Zhu G, Nestler JE, Heath AC, Martin NG. Genetic covariation between serum gamma-glutamyl-transferase activity and cardiovascular risk factors. Clin Chem. 2002;48:1426–1431
  37. Araújo LM, Lima DS, Daltro C. Association of gamma-glutamyl transferase and the metabolic syndrome in obese women. Arq Bras Endocrinol Metab. 2005;49:557–562
  38. Setji TL, Holland ND, Sanders LL, Pereira KC, Diehl AM, Brown AJ. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:1741–1747

 Supported in part by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Ministério da Saúde do Brasil, and Fundação de Apoio à Pesquisa do Estado do Rio Grande do Norte (FAPERN) (Convênio 0146.00/04-CNPq/FAPERN, projeto: 673.923254).

PII: S0015-0282(07)00820-5

doi: 10.1016/j.fertnstert.2007.03.081

Fertility and Sterility
Volume 89, Issue 3 , Pages 649-655 , March 2008

Article Tools